Bender Robert & Associates Sells 890 Shares of Gilead Sciences, Inc. (NASDAQ:GILD)
Bender Robert & Associates cut its holdings in shares of Gilead Sciences, Inc. (NASDAQ:GILD – Free Report) by 2.9% during the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 30,138 shares of the biopharmaceutical company’s stock after selling 890 shares during […]